FindTrial
Sign In

The reasearch of iron in prostate cancer and benigh prostate disease based on multi-parametric magnetic resonance imaging

The reasearch of iron in prostate cancer and benigh prostate disease based on multi-parametric magnetic resonance imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059228
Enrollment
Unknown
Registered
2022-04-27
Start date
2022-04-27
Completion date
Unknown
Last updated
2024-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Gold Standard:Pathological results
Index test:T2* mapping

Sponsors

The first affiliated hospital of soochow university
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. More than 40 years old; 2. No history of interference such as acute prostatitis and severe urinary tract infection; 3. No neoadjuvant chemotherapy or ADT treatment before operation; 4. No prostate surgery other than puncture was performed within one year before the operation.

Exclusion criteria

Exclusion criteria: 1. Endocrine treatment before operation; 2. The interval between MR and surgery is>3 months.

Design outcomes

Primary

MeasureTime frame
Iron;—

Countries

China

Contacts

Public ContactHuang Yuhua

The first affiliated hospital of soochow university

sdfyyy_hyh@163.com+86 15501696620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026